Last time we commented on Eco Animal Health (ECO) we weren't surprised to see chairman Peter Lawrence sell down some of his stake to benefit from the extraordinary share price gains over the past year. Since then, the company has reported strong sales growth for the first five months of the current financial year, and received its first non-European marketing authorisation for its antibiotic Aivlosin. Unsurprisingly the share price has continued to rocket and Mr Lawrence has decided to take another bonus, this time selling 140,000 shares for £700,000.
It would appear he hasn't been the only one taking profits, as the share price stumbled back to 470p after reaching its all-time high of 512p. But the stock could still climb higher. Last month's regulatory approval by the Food and Drug Administration in Thailand marks Eco's first foray out of Europe and the group plans to continue attacking the international market. These plans are likely to be buoyed by global demand for more efficient animal antibiotics to curb the resistance crisis.
Buys | |||||||
---|---|---|---|---|---|---|---|
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
Active Energy | Brian Evans-Jones (fd) | 01 Nov 16 | 150,000 | 2.86 | 4,290 | 1,650,000 | 0.250 |
Active Energy♥ | Matteo Girlanda | 02 Nov 16 | 66,000 | 3.2 | 2,112 | 63,426,000 | 9.622 |
Active Energy | Richard Spinks (ceo) | 01 Nov 16 | 63,000 | 3 | 1,890 | 10,225,000 | 1.551 |
Active Energy | Michael Rowan | 01 Nov 16 | 160,000 | 2.9 | 4,640 | 160,000 | 0.024 |
AstraZeneca♥ | Graham Chipchase | 27 Oct 16 | 100 | 4807.95 | 4,808 | 3,100 | 0.000 |
Barratt Developments | John Allan (ch) | 31 Oct 16 | 11,103 | 452.7 | 50,263 | 34,205 | 0.003 |
Berendsen | Iain Ferguson (ch) | 27 Oct 16 | 10,000 | 1033 | 103,300 | 120,000 | 0.070 |
Berendsen | James Drummond (ceo) | 28 Oct 16 | 10,000 | 994 | 99,400 | 20,000 | 0.012 |
BlackRock Smaller Companies Trust | Robert Robertson | 28 Oct 16 | 5,000 | 901 | 45,050 | 91,062 | 0.190 |
CLS Holdings♥ | John Whiteley (cfo) | 02 Nov 16 | 404 | 1527 | 6,169 | 14,000 | 0.034 |
CVS | Richard Connell (ch) | 28 Oct 16 | 2,109 | 878.5 | 18,528 | 100,000 | 0.166 |
Crossrider | Ido Erlichman (ceo) | 27 Oct 16 | 100,000 | 35 | 35,000 | 100,000 | 0.071 |
Crossrider | Moran Laufer (cfo) | 27 Oct 16 | 50,000 | 35 | 17,500 | 50,000 | 0.035 |
Cyan Holdings* | John Read | 01 Nov 16 | 898,055 | 0.18 | 1,616 | 50,326,751 | 0.333 |
Cyan Holdings* | John Cronin (ch) | 01 Nov 16 | 10,803,574 | 0.18 | 19,446 | 325,549,361 | 2.156 |
Cyan Holdings* | Henry Berry | 01 Nov 16 | 4,165,856 | 0.18 | 7,499 | 75,771,514 | 0.502 |
Cyan Holdings* | Simon Smith (cfo) | 01 Nov 16 | 4,873,822 | 0.18 | 8,773 | 187,884,843 | 1.244 |
Cyan Holdings* | Paul Ratcliff | 01 Nov 16 | 989,259 | 0.18 | 1,781 | 9,702,563 | 0.064 |
EG Solutions | George Rolls | 31 Oct 16 | 16,450 | 49.5 | 8,143 | 16,450 | 0.073 |
EG Solutions | Nigel Payne (ch) | 31 Oct 16 | 16,450 | 49.5 | 8,143 | 16,450 | 0.073 |
Equiniti | Guy Wakeley (ceo) | 02 Nov 16 | 5,128 | 195 | 10,000 | 1,319,813 | 0.440 |
Inchcape | John Langston | 01 Nov 16 | 302 | 650.5 | 1,965 | 3,314 | 0.001 |
Inchcape | Alison Cooper | 01 Nov 16 | 242 | 650.5 | 1,574 | 5,069 | 0.001 |
Inchcape | Coline McConville | 01 Nov 16 | 302 | 650.5 | 1,965 | 1,923 | 0.000 |
Inchcape | Nigel Stein | 01 Nov 16 | 241 | 650.5 | 1,568 | 9,315 | 0.002 |
Inchcape | Till Vestring | 01 Nov 16 | 426 | 650.5 | 2,771 | 64,389 | 0.015 |
JPMorgan Mid Cap Investment Trust | Richard Huntingford | 02 Nov 16 | 6,000 | 866 | 51,960 | 7,500 | 0.031 |
Legal & General | Richard Meddings | 01 Nov 16 | 1,317 | 208.8 | 2,750 | 22,492 | 0.000 |
Legal & General | Carolyn Bradley | 01 Nov 16 | 857 | 208.8 | 1,789 | 14,891 | 0.000 |
Legal & General | Rudy Markham | 01 Nov 16 | 2,376 | 208.8 | 4,961 | 292,904 | 0.005 |
Legal & General | Stuart Popham | 01 Nov 16 | 972 | 208.8 | 2,030 | 67,658 | 0.001 |
Midwich♥ | Andrew Herbert (ch) | 28 Oct 16 | 10,000 | 220 | 22,000 | 20,000 | 0.025 |
North Midland Construction♥ | Robert Moyle (ch) | 28 Oct 16 | 3,200 | 160 | 5,120 | 464,608 | 4.577 |
Oakley Capital Investments | Peter Dubens | 27 Oct 16 | 260,000 | 146.5 | 380,900 | 1,410,000 | 0.743 |
Pacific Assets Trust | Robert Talbut | 02 Nov 16 | 4,729 | 252.25 | 11,929 | 4,729 | 0.004 |
Parity | Alan Rommel (ceo) | 28 Oct 16 | 200,000 | 8 | 16,000 | 210,632 | 0.207 |
Parity | David Firth | 01 Nov 16 | 100,000 | 8.75 | 8,750 | 100,000 | 0.098 |
Parity | Roger Antony (fd) | 28 Oct 16 | 100,000 | 8 | 8,000 | 100,000 | 0.098 |
Pendragon♥ | Mel Egglenton (ch) | 28 Oct 16 | 132,971 | 29.857 | 39,701 | 448,223 | 0.031 |
Pendragon | Jeremy King | 28 Oct 16 | 66,483 | 29.857 | 19,850 | 145,030 | 0.010 |
Pendragon | Martin Casha | 28 Oct 16 | 664,869 | 29.857 | 198,510 | 8,794,301 | 0.610 |
Pendragon | Trevor Finn (ceo) | 28 Oct 16 | 997,306 | 29.857 | 297,766 | 18,216,623 | 1.265 |
Schroder UK Mid Cap Fund | Robert Talbut | 28 Oct 16 | 2,564 | 414 | 10,615 | 5,064 | 0.014 |
Shires Income | Robert Talbut | 27 Oct 16 | 5,471 | 218 | 11,927 | 10,471 | 0.035 |
Time Out | Julio Bruno (ceo) | 28 Oct 16 | 70,624 | 141 | 99,580 | 70,624 | 0.054 |
Utilitywise♥ | Brendan Flattery (ceo) | 31 Oct 16 | 60,000 | 165.369 | 99,221 | 60,000 | 0.077 |
VPC Specialty Lending Investments♥ | Richard Levy | 31 Oct 16 | 78,287 | 80 | 62,630 | 1,033,076 | 0.270 |
Venn Life Sciences Holdings | Allan Wood (ch) | 31 Oct 16 | 65,000 | 21.5 | 13,975 | 65,000 | 0.108 |
Venn Life Sciences Holdings | Allan Wood (ch) | 01 Nov 16 | 165,000 | 21.73 | 35,855 | 230,000 | 0.382 |
Sells | |||||||
---|---|---|---|---|---|---|---|
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
Eco Animal Health♥ | Peter Lawrence (ch) | 28 Oct 16 | 140,000 | 500 | 700,000 | 9,798,477 | 15.077 |
Equiniti♥ | John Stier (cfo) | 27 Oct 16 | 30,000 | 20.329 | 6,099 | 448,910 | 0.150 |
Equiniti | John Stier (cfo) | 27 Oct 16 | 295,000 | 20.329 | 59,971 | 478,910 | 0.160 |
Equiniti | Kevin Beeston (ch) | 27 Oct 16 | 368,914 | 203.29 | 749,965 | 506,304 | 0.169 |
GW Pharmaceuticals | Geoffrey Guy (ch) | 27 Oct 16 | 138,318 | 804 | 1,112,077 | 13,379,534 | 4.424 |
GW Pharmaceuticals | Geoffrey Guy (ch) | 28 Oct 16 | 31,682 | 790 | 250,288 | 13,347,852 | 4.413 |
GlaxoSmithKline | Sir Andrew Witty (ceo) | 27 Oct 16 | 10,000 | 1636.5 | 163,650 | 1,154,886 | 0.024 |
InterContinental Hotels♥ | Richard Solomons | 31 Oct 16 | 37,340 | 3156.685 | 1,178,706 | 403,315 | 0.204 |
Surgical Innovations♥ | Nigel Rogers (ch) | 01 Nov 16 | 483,809 | 3.125 | 15,119 | 2,140,000 | 0.438 |
Surgical Innovations | Nigel Rogers (ch) | 01 Nov 16 | 723,222 | 3.125 | 22,601 | 2,623,809 | 0.537 |
* placing/tender/open offer ♥ spouse/connected party |